secwatch.observer — SEC 8-K summary
======================================

Issuer:     BullFrog AI Holdings, Inc. (BFRG)
CIK:        0001829247
Form:       8-K
Filed at:   2026-03-30T23:59:59+00:00
Accession:  0001493152-26-013684
Event type: other_material
Sentiment:  positive
Materiality: 0.65
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BullFrog AI signs feasibility agreement with top-5 pharma for MDD target discovery
--------------------------------------------------------------------------------

- Agreement with top-5 global pharma (by 2025 revenue) for bfLEAP platform to identify novel drug targets in major depressive disorder (MDD).
- One-year feasibility deal with milestone payments upon delivery of deliverables; client gets exclusive three-year option on a selected final target.
- MDD market valued >$8B in 2025, expected ~$11B by 2032, per Stellar Market Research.
- CEO Vin Singh calls it 'strong, high-quality validation' and expects the relationship to expand across other R&D areas.
- Agreement filed as exhibit; termination clauses allow 30-day notice for no-cause termination from client.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1829247/000149315226013684/0001493152-26-013684-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1829247/000149315226013684/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-013684

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer